EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In situ pulmonary thrombosis and pulmonary embolus are distinct thrombotic phenotypes in critically ill patients with COVID-19 Acute Respiratory Distress Syndrome

Daniël G Aynekulu Mersha, Boaz Lopuhaä, Hester A Gietema, Jim Smit, Anne E Wind, Anne-Marije Hulshof, Katrijn Daenen, Jessica Khyali, Bas C T van Bussel, Matthijs F M van Oosterhout, Hazra S Moeniralam, Eva K Kempers und 9 weitere

Journal of Thrombosis and Haemostasis · 2026

DOI: 10.1016/j.jtha.2025.10.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Daniël G Aynekulu Mersha und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Viroscience, Erasmus University …. Hauptthemen laut MEDLINE: COVID-19, Pulmonary Embolism, Thrombosis, Respiratory Distress Syndrome. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LEO Pharma Research Foundation, Netherlands Organisation for Health Research and Development, Hartstichting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pulmonary embolism (PE) is thought to originate from distal thrombosis. However, in hyperinflammatory conditions, such as COVID-19, thrombosis in the lung vasculature may occur independently of peripheral thrombosis, denoted as in situ thrombosis (IST). OBJECTIVES: We hypothesize that IST results from a dysregulated immune response involving both T-helper type 1 (Th1) and non-Th1 cell upregulation and can be distinguished from PE by histologic, serologic, and radiologic features. METHODS: This study included critically ill patients who succumbed to COVID-19 and from whom pulmonary histopathological examination was obtained. Patients were categorized based on histologic characteristics as either IST (thrombus originating from the vessel wall, with a disorganized structure) or PE (centrally in the vessel, with a layered structure) or as controls (without any pulmonary thrombosis). Inflammation, endothelial activity, and hemostasis biomarkers were measured in blood, and computed tomography scans were analyzed. RESULTS: Of 21 included patients, n = 6 were categorized as IST, n = 8 as PE, and n = 7 as controls (those who did not have pulmonary thrombosis). Radiologic features of IST included irregular filling defects along vessel walls in smaller arteries in areas with infiltrates. Patients with IST had higher levels of interleukin [IL]-17, IL-18 and IL-33 than those with PE and controls, indicating upregulation of both Th1 and non-Th1 cell pathways. CONCLUSION: IST and PE are distinct forms of pulmonary thrombosis. IST originates from the pulmonary vessel wall and is characterized by skewing from an effective immune response to upregulation of Th1, Th2, and Th17 cell pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Pulmonary EmbolismThrombosisRespiratory Distress SyndromeHumansFemaleMaleMiddle AgedCritical IllnessAgedPhenotypeSARS-CoV-2Th1 CellsBiomarkersAdultCase-Control StudiesLung

Stichwörter der Autor:innen

Th1 cellsTh17 cellsTh2 cellsThrombosistomographyx-ray computed

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Intensive Care, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Viroscience, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic addre…
  • Department of Pathology and Clinical Bioinformatics, Erasmus MC, Rotterdam, The Netherlands.
  • Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre (MUMC)+, Maastricht, The Netherlands; GROW, Research Institute of Oncology and Reproduction, Maastricht University, Maastricht, The Neth…
  • Department of Intensive Care, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands; Data Science Group, Institute for Computing and Information Sciences, Radboud University, Nijmegen, The Netherlands;…
  • ILD Center of Excellence, member of European Reference Network-Lung, St Antonius Hospital, Nieuwegein, The Netherlands.
  • Central Diagnostic Laboratory, Maastricht University Medical Center+, Maastricht, The Netherlands.

Förderung

  • LEO Pharma Research Foundation
  • Netherlands Organisation for Health Research and Development
  • Hartstichting
  • HORIZON EUROPE Framework Programme
  • Actelion Pharmaceuticals

Zitieren

APA

Aynekulu Mersha, D. G., Lopuhaä, B., Gietema, H. A., Smit, J., Wind, A. E., Hulshof, A. M., Daenen, K., Khyali, J., van Bussel, B. C. T., van Oosterhout, M. F. M., Moeniralam, H. S., Kempers, E. K., Kruip, M. J. H. A., Klok, F. A., Dalm, V. A. S. H., Endeman, H., Van Gorp, E. C. M., Dik, W. A., von der Thüsen, J. H., …, & Dutch COVID and Thrombosis Coalition (2026). In situ pulmonary thrombosis and pulmonary embolus are distinct thrombotic phenotypes in critically ill patients with COVID-19 Acute Respiratory Distress Syndrome. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.10.021

Vancouver

Aynekulu Mersha DG, Lopuhaä B, Gietema HA, Smit J, Wind AE, Hulshof AM, et al. In situ pulmonary thrombosis and pulmonary embolus are distinct thrombotic phenotypes in critically ill patients with COVID-19 Acute Respiratory Distress Syndrome. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2025.10.021

BibTeX
@article{AynekuluMersha2026,
  author = {Aynekulu Mersha, Daniël G and Lopuhaä, Boaz and Gietema, Hester A and Smit, Jim and Wind, Anne E and Hulshof, Anne-Marije and Daenen, Katrijn and Khyali, Jessica and van Bussel, Bas C T and van Oosterhout, Matthijs F M and Moeniralam, Hazra S and Kempers, Eva K and Kruip, Marieke J H A and Klok, Frederikus A and Dalm, Virgil A S H and Endeman, Henrik and Van Gorp, Eric C M and Dik, Willem A and von der Thüsen, Jan H and Juffermans, Nicole P and Dutch COVID and Thrombosis Coalition, Dutch COVID and Thrombosis Coalition},
  title = {In situ pulmonary thrombosis and pulmonary embolus are distinct thrombotic phenotypes in critically ill patients with COVID-19 Acute Respiratory Distress Syndrome},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1016/j.jtha.2025.10.021}
}
Kostenlos starten →